Volume overhydration is related to endothelial dysfunction in continuous ambulatory peritoneal dialysis patients

Peritoneal Dialysis International

Volumn 28, Issue 4, 2008, Pages 397-402

  Cheng, Li Tao ^a   Gao, Yan Li ^a,b   Qin, Chao ^a,c   Tian, Jun Ping ^a,d   Gu, Yue ^a   Bi, Shu Hong ^a   Tang, Wen ^a   Wang, Tao ^a  

^a PEKING UNIVERSITY THIRD HOSPITAL   (China)

^b GUANGZHOU UNIVERSITY OF CHINESE MEDICINE   (China)

^c SHANDONG UNIVERSITY   (China)

^d CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Endothelial function; Flow mediated dilatation; Volume status

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; PHOSPHATE;

ADULT; ARTERY DIAMETER; ARTERY DILATATION; ARTICLE; BODY HEIGHT; BODY MASS; BODY WEIGHT; BRACHIAL ARTERY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC GLOMERULONEPHRITIS; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; ENDOTHELIAL DYSFUNCTION; EXTRACELLULAR FLUID; FEMALE; HUMAN; HYPERTENSION; HYPERVOLEMIA; IMPEDANCE; INTERSTITIAL NEPHRITIS; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION; VOLUMETRY;

EID: 48749092662     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080802800415     Document Type: Article

References (27)

1. Konings CJ, Kooman JP, Schonck M, Struijk DG, Gladziwa U, Hoorntje SJ, et al. Fluid status in CAPD patients is related to peritoneal transport and residual renal function: evidence from a longitudinal study. Nephrol Dial Transplant 2003; 18:797-803.
2. Lin YP, Chen CH, Yu WC, Hsu TL, Ding PY, Yang WC. Left ventricular mass and hemodynamic overload in normotensive hemodialysis patients. Kidney Int 2002; 62:1828-38.
3. Wang MC, Tseng CC, Tsai WC, Huang JJ. Blood pressure and left ventricular hypertrophy in patients on different peritoneal dialysis regimens. Perit Dial Int 2001; 21:36-42.
4. Konings CJ, Kooman JP, Schonck M, Dammers R, Cheriex E, Palmans Meulemans AP, et al. Fluid status, blood pressure, and cardiovascular abnormalities in patients on peritoneal dialysis. Perit Dial Int 2002; 22:477-87.
5. Lameire N, Van BW. Importance of blood pressure and volume control in peritoneal dialysis patients. Perit Dial Int 2001; 21:206-11.
6. Landmesser U, Drexler H. The clinical significance of endothelial dysfunction. Curr Opin Cardiol 2005; 20:547-51.
7. Anderson EA, Mark AL. Flow-mediated and reflex changes in large peripheral artery tone in humans. Circulation 1989; 79:93-100.
8. Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID, et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992; 340:1111-15.
9. Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA, et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 2002; 39:257-65.
10. Davies SJ, Woodrow G, Donovan K, Plum J, Williams P, Johansson AC, et al. Icodextrin improves the fluid status of peritoneal dialysis patients: results of a double-blind randomized controlled trial. J Am Soc Nephrol 2003; 14: 2338-44.
11. Kuvin JT, Patel AR, Sliney KA, Pandian NG, Rand WM, Udelson JE, et al. Peripheral vascular endothelial function testing as a noninvasive indicator of coronary artery disease. J Am Coll Cardiol 2001; 38:1843-9.
12. Lunde P, Baksaas I, Halse M, Strommes B, Aeydvin K. The methodology of drug utilization studies. In: Bergman U, Grimsson A, Wahba AHW, Werterholm B, eds. Studies in Drug Utilization. Copenhagen: WHO Regional Office for Europe; 1979: 17-28.
13. Nolph KD, Moore HL, Prowant B, Meyer M, Twardowski ZJ, Khanna R, et al. Cross-sectional assessment of weekly urea and creatinine clearance and indices of nutrition in continuous ambulatory peritoneal dialysis patients. Perit Dial Int 1993; 13:178-83.
14. Watson P, Watson I, Batt R. Total body water volumes for adult males and females estimated from simple anthropometric measurements. Am J Clin Nutr 1980; 33:27-39.
15. Joannides R, Haefeli WE, Linder L, Richard V, Bakkali EH, Thuillez C, et al. Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. Circulation 1995; 91:1314-19.
16. Panza JA, Quyyumi AA, Brush JE Jr, Epstein SE. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med 1990; 323:22-7.
17. Ghiadoni L, Taddei S, Virdis A, Sudano I, Di Legge V, Meola M, et al. Endothelial function and common carotid artery wall thickening in patients with essential hypertension. Hypertension 1998; 32:25-32.
18. Muiesan ML, Salvetti M, Monteduro C, Corbellini C, Guelfi D, Rizzoni D, et al. Flow-mediated dilatation of the brachial artery and left ventricular geometry in hypertensive patients. J Hypertens 2001; 19:641-7.
19. Lins RL, Elseviers M, Rogiers P, Van Hoeyweghen RJ, De Raedt H, Zachee P, et al. Importance of volume factors in dialysis related hypertension. Clin Nephrol 1997; 48: 29-33.
20. Aguilera A, Codoceo R, Selgas R, Garcia P, Picornell M, Diaz C, et al. Anorexigen (TNF-alpha, cholecystokinin) and orexigen (neuropeptide Y) plasma levels in peritoneal dialysis (PD) patients: their relationship with nutritional parameters. Nephrol Dial Transplant 1998; 13:1476-83.
21. Niebauer J, Volk HD, Kemp M, Dominguez M, Schumann RR, Rauchhaus M, et al. Endotoxin and immune activation in chronic heart failure: a prospective cohort study. Lancet 1999; 353:1838-42.
22. Dogra G, Irish A, Chan D, Watts G. Insulin resistance, inflammation, and blood pressure determine vascular dysfunction in CKD. Am J Kidney Dis 2006; 48:926-34.
23. Yilmaz MI, Saglam M, Carrero JJ, Qureshi AR, Caglar K, Eyileten T, et al. Serum visfatin concentration and endothelial dysfunction in chronic kidney disease. Nephrol Dial Transplant 2008; 23:959-65.
24. Kosch M, Hausberg M, Vormbrock K, Kisters K, Rahn KH, Barenbrock M. Studies on flow-mediated vasodilation and intima-media thickness of the brachial artery in patients with primary hyperparathyroidism. Am J Hypertens 2000; 13:759-64.
25. Neunteufl T, Katzenschlager R, Abela C, Kostner K, Niederle B, Weidinger F, et al. Impairment of endothelium-independent vasodilation in patients with hypercalcemia. Cardiovasc Res 1998; 40:396-401.
26. Bortotolotto LA, Costa-Hong V, Jorgetti V, Consolim-Colombo F, Rosa K, Silva BC, et al. Vascular changes in chronic renal disease patients with secondary hyperparathyroidism. J Nephrol 2007; 20:66-72.
27. Block GA, Port FK. Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: recommendations for a change in management. Am J Kidney Dis 2000; 35:1226-37.